Glenview Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-98,578
| Closed | -$53.4M | – | 50 |
|
|
2024
Q2 | $53.4M | Sell |
98,578
-75,651
| -43% | -$40M | 1.05% | 27 |
|
|
2024
Q1 | $90.3M | Buy |
174,229
+136,320
| +360% | +$67.8M | 1.58% | 20 |
|
|
2023
Q4 | $17.9M | Buy |
37,909
+22,982
| +154% | +$10.6M | 0.38% | 32 |
|
|
2023
Q3 | $6.5M | Buy |
+14,927
| New | +$6.77M | 0.15% | 44 |
|
|
2023
Q2 | – | Sell |
-11,867
| Closed | -$5.46M | – | 54 |
|
|
2023
Q1 | $5.46M | Buy |
+11,867
| New | +$5.65M | 0.12% | 48 |
|
|
2021
Q4 | – | Sell |
-88,011
| Closed | -$32.8M | – | 59 |
|
|
2021
Q3 | $32.8M | Sell |
88,011
-84,702
| -49% | -$32.2M | 0.6% | 41 |
|
|
2021
Q2 | $65.9M | Sell |
172,713
-90,920
| -34% | -$34.7M | 1.09% | 35 |
|
|
2021
Q1 | $94.6M | Buy |
263,633
+79,172
| +43% | +$25.5M | 1.6% | 18 |
|
|
2020
Q4 | $59.2M | Buy |
+184,461
| New | +$56.6M | 1.36% | 22 |
|
|
2020
Q1 | – | Sell |
-751,142
| Closed | -$227M | – | 49 |
|
|
2019
Q4 | $227M | Sell |
751,142
-116,885
| -13% | -$32.2M | 1.99% | 18 |
|
|
2019
Q3 | $208M | Sell |
868,027
-2,790
| -0.3% | -$764K | 2.19% | 15 |
|
|
2019
Q2 | $246M | Sell |
870,817
-147,420
| -14% | -$40.3M | 2.23% | 15 |
|
|
2019
Q1 | $292M | Buy |
1,018,237
+145,804
| +17% | +$42.2M | 2.61% | 14 |
|
|
2018
Q4 | $229M | Sell |
872,433
-414,516
| -32% | -$114M | 2.22% | 15 |
|
|
2018
Q3 | $353M | Buy |
1,286,949
+11,287
| +0.9% | +$2.93M | 2.24% | 19 |
|
|
2018
Q2 | $304M | Sell |
1,275,662
-1,005,673
| -44% | -$233M | 2.07% | 20 |
|
|
2018
Q1 | $501M | Sell |
2,281,335
-776,162
| -25% | -$182M | 2.93% | 12 |
|
|
2017
Q4 | $688M | Sell |
3,057,497
-745,018
| -20% | -$159M | 3.72% | 7 |
|
|
2017
Q3 | $722M | Sell |
3,802,515
-248,116
| -6% | -$47.2M | 4.19% | 6 |
|
|
2017
Q2 | $762M | Sell |
4,050,631
-661,014
| -14% | -$119M | 4.94% | 5 |
|
|
2017
Q1 | $779M | Sell |
4,711,645
-1,162,404
| -20% | -$185M | 5.17% | 3 |
|
|
2016
Q4 | $845M | Buy |
5,874,049
+276,807
| +5% | +$37.1M | 5.71% | 3 |
|
|
2016
Q3 | $701M | Buy |
5,597,242
+1,637,826
| +41% | +$211M | 5.02% | 5 |
|
|
2016
Q2 | $520M | Buy |
3,959,416
+314,600
| +9% | +$43M | 3.68% | 9 |
|
|
2016
Q1 | $507M | Sell |
3,644,816
-659,249
| -15% | -$88.1M | 3.7% | 11 |
|
|
2015
Q4 | $600M | Buy |
4,304,065
+53,664
| +1% | +$7.39M | 3.38% | 10 |
|
|
2015
Q3 | $595M | Sell |
4,250,401
-369,265
| -8% | -$55.5M | 2.95% | 9 |
|
|
2015
Q2 | $758M | Sell |
4,619,666
-273,934
| -6% | -$43.8M | 3% | 8 |
|
|
2015
Q1 | $756M | Buy |
4,893,600
+1,300,955
| +36% | +$185M | 3.45% | 5 |
|
|
2014
Q4 | $451M | Sell |
3,592,645
-443,800
| -11% | -$54.8M | 2.26% | 15 |
|
|
2014
Q3 | $483M | Sell |
4,036,445
-479,355
| -11% | -$55M | 2.52% | 11 |
|
|
2014
Q2 | $486M | Buy |
4,515,800
+283,850
| +7% | +$29.2M | 2.81% | 12 |
|
|
2014
Q1 | $421M | Buy |
+4,231,950
| New | +$383M | 2.76% | 12 |
|
Other funds holding ELV
Glenview Capital Management's ELV Position: Q3 2024 in Review
Glenview Capital Management sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 98,578 shares — an estimated $53.4M sold.
Glenview Capital Management first reported a position in ELV in Q1 2014 and held it in 33 quarters. The position peaked at $845M in Q4 2016. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.
- Glenview Capital Management reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
- Glenview Capital Management sold 98,578 Elevance Health shares in Q3 2024, an estimated $53.4M.
- Glenview Capital Management first reported a position in Elevance Health in Q1 2014 and held it in 33 quarters.
- Glenview Capital Management's Elevance Health position peaked at $845M in Q4 2016.
- 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.
Based on Glenview Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.